BANDARAM PHARMA PACKTECH LIMITED

BSE: BANDARAM524602ISIN INE875N01036

Healthcare
Healthcare Service Provider

BSE listing

Share price

₹20.99+0.21 (+1.01%)

as of 18 Sep 2026

52W high: ₹49.70
52W low: ₹17.25
Off 52W high: -57.77%
1M return: +19.74%
3M return: -29.06%
6M return: -23.67%
1Y return: -34.59%
20D avg volume: 5,720
50 DMA: ₹20.53
200 DMA: ₹26.62

Key ratios Consolidated

Market cap: ₹37.72 Cr
Current price: ₹20.99
52W high / low: ₹49.70 / ₹17.25
Face value: ₹10.00
P/E: 31.46
P/B: —
EPS (TTM): ₹0.67
Book value / share: —
ROE: —
ROCE: 4.70%
Operating margin: —
Net margin: —
Debt / equity: 0.76
Net debt: ₹23.22 Cr
Interest cover: 1.29
Dividend yield: 0.48%
Dividend / share (TTM): ₹0.10
Payout: 14.93%
Cash conversion cycle: 162.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	23.95	26.26	14.84	13.72	8.10	8.49	—
	0.00	0.01	0.00	0.01	0.00	0.09	—
	23.03	26.13	14.31	13.66	8.07	8.38	—
	21.61	23.13	14.02	10.89	6.48	4.38	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.73	2.25	0.58	0.53	0.55	1.08	—
	0.42	0.46	0.33	0.25	0.46	-0.10	—
	0.20	0.25	0.14	0.14	0.13	0.53	—
	0.92	1.14	0.67	0.43	0.51	0.32	—
	0.92	0.14	0.53	0.08	0.04	0.20	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.92	0.14	0.53	0.08	0.04	0.20	—
	0.24	0.03	0.18	0.02	0.01	0.04	—
	0.68	0.11	0.35	0.06	0.02	0.16	—
	0.11	0.06	0.11	0.03	0.01	0.13	—
Key metrics
	1.54	0.85	1.00	0.47	0.63	0.63	—
	6.40%	3.20%	6.70%	3.40%	7.80%	7.40%	—
	2.80%	0.40%	2.40%	0.40%	0.20%	1.90%	—
	—	1.40%	—	1.30%	—	0.40%	—
	195.70%	209.30%	—	—	—	—	—
	3,300.00%	-31.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	78.77	62.92	36.96	—
	0.02	0.02	0.09	—
	77.13	62.50	35.74	—
	69.65	55.02	30.96	—
	0.00	0.00	0.00	—
	4.09	3.91	2.96	—
	1.46	1.51	0.61	—
	0.73	0.97	0.99	—
	3.16	2.26	1.53	—
	1.67	0.44	1.32	—
	0.00	0.00	0.00	—
	1.67	0.44	1.32	—
	0.47	0.16	0.32	—
	1.20	0.28	0.99	—
	0.31	0.83	0.83	—
Key metrics
	3.86	2.92	2.92	—
	4.90%	4.60%	7.90%	—
	1.52%	0.40%	2.70%	—
	—	4.70%	7.80%	—
	—	70.20%	—	—
	—	-71.70%	—	—
	—	-4.92	-5.01	—
	—	-17.57	-4.98	—
	—	0.76	1.08	—
	—	23.22	17.03	—
	—	162.7	226.2	—
Balance sheet
	—	75.86	38.92	—
	—	56.99	30.88	—
	—	0.72	0.12	—
	—	31.35	18.76	—
	—	12.94	8.51	—
	—	3.59	0.00	—
	—	9.41	3.95	—
	—	16.26	4.36	—
	—	34.33	14.03	—
	—	23.94	17.15	—
	—	13.89	8.16	—
	—	10.05	8.99	—
	—	31.37	15.82	—
Cash flow
	—	-4.92	-4.93	—
	—	0.00	-0.08	—
	—	5.53	5.09	—
	—	0.00	0.08	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	2.99	8.20	1.68	0.33	0.76	3.71	—
	0.00	0.00	0.00	0.01	0.00	0.09	—
	3.34	8.53	1.89	0.69	1.03	3.75	—
	2.76	7.86	1.66	0.33	0.80	3.11	—
	0.00	0.00	0.00	0.00	-0.04	0.00	—
	0.28	0.55	0.11	0.11	0.11	0.45	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.30	0.12	0.11	0.25	0.16	0.18	—
	-0.36	-0.33	-0.21	-0.35	-0.27	0.06	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.36	-0.33	-0.21	-0.35	-0.27	0.06	—
	0.00	0.00	0.00	0.00	0.00	0.01	—
	-0.36	-0.33	-0.21	-0.35	-0.27	0.04	—
	0.20	-0.18	-0.12	-0.29	-0.22	0.04	—
Key metrics
	-0.36	-0.33	-0.21	-0.35	-0.27	0.06	—
	-12.00%	-4.00%	-12.50%	-106.10%	-35.50%	1.60%	—
	-12.00%	-4.00%	-12.50%	-106.10%	-35.50%	1.10%	—
	—	-1.20%	—	-2.30%	—	0.40%	—
	293.40%	121.00%	—	—	—	—	—
	-33.30%	-925.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	13.20	10.96	12.23	—
	0.01	0.01	0.09	—
	14.45	12.13	12.14	—
	12.61	10.60	10.44	—
	0.00	0.00	0.00	—
	1.05	0.88	1.10	—
	0.00	0.00	0.00	—
	0.00	0.00	0.01	—
	0.78	0.64	0.59	—
	-1.25	-1.16	0.19	—
	0.00	0.00	0.00	—
	-1.25	-1.16	0.19	—
	0.00	0.00	0.05	—
	-1.25	-1.16	0.14	—
	-0.39	-0.64	0.12	—
Key metrics
	-1.25	-1.16	0.20	—
	-9.47%	-10.60%	1.60%	—
	-9.47%	-10.60%	1.10%	—
	—	-4.20%	1.20%	—
	—	-10.40%	—	—
	—	-928.60%	—	—
	—	-0.79	-3.25	—
	—	-1.04	-23.21	—
	—	0.20	0.29	—
	—	4.25	3.46	—
	—	134.9	157.6	—
Balance sheet
	—	36.61	19.21	—
	—	15.21	12.62	—
	—	0.26	0.02	—
	—	10.67	6.62	—
	—	2.08	1.64	—
	—	1.69	1.58	—
	—	0.00	0.00	—
	—	8.70	2.98	—
	—	9.21	3.62	—
	—	4.51	3.48	—
	—	0.00	0.00	—
	—	4.51	3.48	—
	—	22.89	12.10	—
Cash flow
	—	1.21	-3.25	—
	—	-2.00	0.00	—
	—	1.03	3.23	—
	—	2.00	0.00	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 62.67%

Holder	Type	Holding	Previous	Change
DEEPAK REDDY B	Promoter	35.28%	—	—
PREM SAI REDDY B	Promoter	10.46%	—	—
BHANDARAM SATHYAVATHI	Promoter	10.46%	—	—
SANIVARAPU JHANSI	Public	4.37%	—	—
PRAJITHA BANDARAM	Promoter Group	2.71%	—	—
L LALANTHIKA	Promoter	2.50%	—	—
SREEDAR REDDY G	Public	2.23%	—	—
SANIVARAPU NAVYA REDDY	Public	2.08%	—	—
KOLLI SURYATEJA REDDY .	Public	1.86%	—	—
SAPNAA .	Public	1.64%	—	—
VIVEK SURANA	Public	1.49%	—	—
LAKSHMI PILLA	Public	1.34%	—	—
ANURADHA NANNAPANENI	Public	1.34%	—	—
SAHITHI KOLLI .	Public	1.34%	—	—
AKHIL REDDY SANIVARAPU	Public	1.25%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Annual Report for the FY 2025-26.1 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of AGM for the FY 2025-26 Scheduled To Be Held on 24.09.2026.1 Sep 2026 · AGM/EGM / AGM
Change in Management13 Aug 2026 · Company Update / Change in Management
Un-Audited Financial Results (Standalone & Consolidated) for Quater ended 30.06.202613 Aug 2026 · Result / Financial Results
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. Un-Audited standalone ....6 Aug 2026 · Board Meeting / Board Meeting
Certificate under Reg. 74 (5) of Sebi (DP) Regulations, 2018.11 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Clarification of Price Movement7 Jul 2026 · Company Update / General
The Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....6 Jul 2026 · Company Update / Clarification
Closure of Trading Window for Un-audited Financial Results(Standalone & Consolidated) for the Quarter ending June 30,2026.24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Receipt of Order11 Jun 2026 · Company Update / General
Resignation of Whole-Time Director of the Company.5 Jun 2026 · Company Update / Resignation of Director
Change in Management30 May 2026 · Company Update / Change in Management
Audited Financial Results for the Quarter and Year ended 31.03.202630 May 2026 · Result / Financial Results
Receipt of order29 May 2026 · Company Update / Award of Order / Receipt of Order
Receipt of order29 May 2026 · Company Update / Award of Order / Receipt of Order
Receipt of Order29 May 2026 · Company Update / Award of Order / Receipt of Order
Annual Secretarial Compliance Report for FY ended 31.03.202626 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial ....21 May 2026 · Board Meeting / Board Meeting
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....30 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Scrutinizer''s Report for the EGM of the company for the FY 2026-27 held on 27.04.202627 Apr 2026 · AGM/EGM / EGM
Outcome of EGM of the company for FY 2026-27 held on 27.04.202627 Apr 2026 · AGM/EGM / EGM
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.11 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notice of Extra-Ordinary General Meeting to be held on 27.04.20263 Apr 2026 · AGM/EGM / EGM
Outcome of Board meeting to be held on 03.04.20263 Apr 2026 · Others / Outcome without intimation
Closure of trading window27 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication for Unaudited Financial Results for the quarter and nine months ended 31.12.2025.16 Feb 2026 · Company Update / Newspaper Publication
Outcome of Board meeting held on 13.02.202613 Feb 2026 · Board Meeting / Outcome of Board Meeting
Unaudited Financial Results for the quarter and nine months ended 31.12.202513 Feb 2026 · Result / Financial Results
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited financial ....3 Feb 2026 · Board Meeting / Board Meeting
changes in management30 Jan 2026 · Company Update / Change in Management
Outcome of Board meeting held on 30.01.202630 Jan 2026 · Others / Outcome without intimation
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 201810 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of trading window for unaudited Financial Results for the quarter ending 31.12.202526 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Clarification on Price Movement2 Dec 2025 · Company Update / General
The Exchange has sought clarification from Bandaram Pharma Packtech Ltd on December 2, 2025, with reference to Movement in Price. The reply is awaited.2 Dec 2025 · Company Update / Clarification
Outcome of Board meeting held on 13.11.202513 Nov 2025 · Board Meeting / Outcome of Board Meeting
Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30.09.202513 Nov 2025 · Result / Financial Results
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for B Premsai Reddy & PACs8 Nov 2025 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Reddy B & PACs7 Nov 2025 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.1000	22 Sep 2025	22 Sep 2025	—
Final Dividend - Rs. - 0.1000	20 Sep 2024	—	—

Board meetings

13 Aug 2026 Board Meeting - Financial Results